Roughly what percentage of patient with metastatic epithelial ovarian cancer will be benefited by treatment with an alkylating agent :: (A) Less than 10 percent, (B) 25 to 49 percent, (C) 50 to 74 percent, (D) 75 to 89 percent
Answer is C. 50 to 74 percent